Cited by 370Cancer, Hypoxia, and MetabolismMetabolism, Diabetes, and CancerCancer, Lipids, and Metabolism

The DOI matches its Crossref record; 119 of the 119 references it cites were found in a registry or an index.

Role of monocarboxylate transporters in human cancers: state of the art

Open access

Pinheiro, Céline, Longatto-Filho, Adhemar, Azevedo-Silva, João, Casal, Margarida, Schmitt, Fernando C., Baltazar, Fátima·2012·Journal of Bioenergetics and Biomembranes

DOI 10.1007/s10863-012-9428-1

Open this paper in CoChat — free account

Abstract

Monocarboxylate transporters (MCTs) belong to the SLC16 gene family, presently composed by 14 members. MCT1-MCT4 are proton symporters, which mediate the transmembrane transport of pyruvate, lactate and ketone bodies. The role of MCTs in cell homeostasis has been characterized in detail in normal tissues, however, their role in cancer is still far from understood. Most solid tumors are known to rely on glycolysis for energy production and this activity leads to production of important amounts of lactate, which are exported into the extracellular milieu, contributing to the acidic microenvironment. In this context, MCTs will play a dual role in the maintenance of the hyper-glycolytic acid-resistant phenotype of cancer, allowing the maintenance of the high glycolytic rates by performing lactate efflux, and pH regulation by the co-transport of protons. Thus, they constitute attractive targets for cancer therapy, which have been little explored. Here we review the literature on the role of MCTs in solid tumors in different locations, such as colon, central nervous system, breast, lung, gynecologic tract, prostate, stomach, however, there are many conflicting results and in most cases there are no functional studies showing the dependence of the tumors on MCT expression and activity. Additional studies on MCT expression in other tumor types, confirmation of the results already published as well as additional functional studies are needed to deeply understand the role of MCTs in cancer maintenance and aggressiveness.

Integrity signals

Registry

Crossref · 10.1007/s10863-012-9428-1

Cites

119 of 119 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

We couldn’t retrieve this paper’s full text, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

On the origin of cancer cells
Warburg, O. (1956) · Science · doi:10.1126/science.123.3191.309 · Cited by 13,425
Why Do Cancers Have High Aerobic Glycolysis?
Gatenby, R. A., & Gillies, R. J. (2004) · Nature reviews. Cancer · doi:10.1038/nrc1478 · Cited by 4,784
HIF-1-mediated expression of pyruvate dehydrogenase kinase: A metabolic switch required for cellular adaptation to hypoxia
Kim, J.-W., Tchernyshyov, I., Semenza, G. L., & Dang, C. V. (2006) · Cell Metabolism · doi:10.1016/j.cmet.2006.02.002 · Cited by 3,905
Beyond aerobic glycolysis: transformed cells can engage in glutamine metabolism that exceeds the requirement for protein and nucleotide synthesis
DeBerardinis, R. J., Mancuso, A., Daikhin, E., Nissim, I., Yudkoff, M., Wehrli, S., & Thompson, C. B. (2007) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0709747104 · Cited by 2,622
HIF-1 mediates adaptation to hypoxia by actively downregulating mitochondrial oxygen consumption
Papandreou, I., Cairns, R. A., Fontana, L., Lim, A. L., & Denko, N. C. (2006) · Cell Metabolism · doi:10.1016/j.cmet.2006.01.012 · Cited by 2,267
Inhibitory effect of tumor cell-derived lactic acid on human T cells
Fischer, K., Hoffmann, P., Voelkl, S., Meidenbauer, N., Ammer, J., Edinger, M., Gottfried, E., Schwarz, S., Rothe, G., Hoves, S., et al. (2007) · Blood · doi:10.1182/blood-2006-07-035972 · Cited by 1,946
Regulation of Mammalian O 2 Homeostasis by Hypoxia-Inducible Factor 1
Semenza, G. L. (1999) · Annual Review of Cell and Developmental Biology · doi:10.1146/annurev.cellbio.15.1.551 · Cited by 1,914 · cited 1×
“The frequency and severity of tumor hypoxia and its association with malignant progression make the hypoxiainduced metabolic adaptations promising targets for cancer therapy (Dang & Semenza 1999).”
Background
Targeting lactate-fueled respiration selectively kills hypoxic tumor cells in mice
Sonveaux, P., Végran, F., Schroeder, T., Wergin, M., Verrax, J., Rabbani, Z. N., Saedeleer, C. J. D., Kennedy, K. M., Diepart, C., Jordan, B. F., et al. (2008) · Journal of Clinical Investigation · doi:10.1172/jci36843 · Cited by 1,635
Differential Roles of Hypoxia-Inducible Factor 1α (HIF-1α) and HIF-2α in Hypoxic Gene Regulation
Hu, C.-J., Wang, L.-Y., Chodosh, L. A., Keith, B., & Simon, M. C. (2003) · Molecular and Cellular Biology · doi:10.1128/mcb.23.24.9361-9374.2003 · Cited by 1,386
The proton-linked monocarboxylate transporter (MCT) family: structure, function and regulation
Halestrap, A. P., & Price, N. T. (1999) · Biochemical Journal · doi:10.1042/bj3430281 · Cited by 1,346

Show all 118 references

Sorted by citations

Tumor glycolysis as a target for cancer therapy: progress and prospects
Ganapathy‐Kanniappan, S., & Geschwind, J.-F. H. (2013) · Molecular Cancer · doi:10.1186/1476-4598-12-152 · Cited by 1,428
HIF-1 mediates metabolic responses to intratumoral hypoxia and oncogenic mutations
Semenza, G. L. (2013) · Journal of Clinical Investigation · doi:10.1172/jci67230 · Cited by 1,335
Targeting Metabolism for Cancer Therapy
Luengo, A., Gui, D. Y., & Vander Heiden, M. G. (2017) · Cell Chemical Biology · doi:10.1016/j.chembiol.2017.08.028 · Cited by 971
Monocarboxylate transporters in cancer
Payen, V. L., Mina, E., Hée, V. F. V., Porporato, P. E., & Sonveaux, P. (2019) · Molecular Metabolism · doi:10.1016/j.molmet.2019.07.006 · Cited by 688
Reexamining cancer metabolism: lactate production for carcinogenesis could be the purpose and explanation of the Warburg Effect
San-Millán, I., & Brooks, G. A. (2016) · Carcinogenesis · doi:10.1093/carcin/bgw127 · Cited by 640
Disrupting proton dynamics and energy metabolism for cancer therapy
Parks, S. K., Chiche, J., & Pouysségur, J. (2013) · Nature reviews. Cancer · doi:10.1038/nrc3579 · Cited by 631
Targeting glucose metabolism to suppress cancer progression: prospective of anti-glycolytic cancer therapy
Abdel-Wahab, A. F., Mahmoud, W., & Al-Harizy, R. M. (2019) · Pharmacological Research · doi:10.1016/j.phrs.2019.104511 · Cited by 598
Coumarins as anticancer agents: A review on synthetic strategies, mechanism of action and SAR studies
Thakur, A., Singla, R., & Jaitak, V. (2015) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2015.07.010 · Cited by 491
3D cell culture systems modeling tumor growth determinants in cancer target discovery
Thoma, C. R., Zimmermann, M., Agarkova, I., Kelm, J. M., & Krek, W. (2014) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2014.03.001 · Cited by 478
Monocarboxylate Transporters (SLC16): Function, Regulation, and Role in Health and Disease
Felmlee, M. A., Jones, R. S., Rodriguez‐Cruz, V., Follman, K. E., & Morris, M. E. (2020) · Pharmacological Reviews · doi:10.1124/pr.119.018762 · Cited by 483
Cancer-associated adipocytes: key players in breast cancer progression
Wu, Q., Li, B., Li, Z., Li, J., Sun, S., & Sun, S. (2019) · Journal of Hematology & Oncology · doi:10.1186/s13045-019-0778-6 · Cited by 462
Role of Monocarboxylate Transporters in Drug Delivery to the Brain
Vijay, N., & Morris, M. (2014) · Current Pharmaceutical Design · doi:10.2174/13816128113199990462 · Cited by 408
Monocarboxylate transporters in the brain and in cancer
Pérez‐Escuredo, J., Hée, V. F. V., Sboarina, M., Falces, J., Payen, V. L., Pellerin, L., & Sonveaux, P. (2016) · Biochimica et Biophysica Acta (BBA) - Molecular Cell Research · doi:10.1016/j.bbamcr.2016.03.013 · Cited by 415
Blocking Lactate Export by Inhibiting the Myc Target MCT1 Disables Glycolysis and Glutathione Synthesis
Doherty, J. R., Yang, C., Scott, K. E. N., Cameron, M. D., Fallahi, M., Li, W., Hall, M. A., Amelio, A. L., Mishra, J. K., Li, F., et al. (2013) · Cancer Research · doi:10.1158/0008-5472.can-13-2034 · Cited by 411
A guide to plasma membrane solute carrier proteins
Pizzagalli, M. D., Bensimon, A., & Superti‐Furga, G. (2020) · FEBS Journal · doi:10.1111/febs.15531 · Cited by 413
Activity of the Monocarboxylate Transporter 1 Inhibitor AZD3965 in Small Cell Lung Cancer
Polański, R., Hodgkinson, C. L., Fusi, A., Nonaka, D., Priest, L., Kelly, P., Trapani, F., Bishop, P. W., White, A., Critchlow, S. E., et al. (2014) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-13-2270 · Cited by 378
Monocarboxylic Acid Transport
Halestrap, A. P. (2013) · Comprehensive physiology · doi:10.1002/cphy.c130008 · Cited by 389
RETRACTED ARTICLE: Targeted production of reactive oxygen species in mitochondria to overcome cancer drug resistance
Wang, H., Gao, Z. J., Liu, X., Agarwal, P., Zhao, S., Conroy, D. W., Ji, G., Yu, J., Jaroniec, C. P., Liu, Z., et al. (2018) · Nature Communications · doi:10.1038/s41467-018-02915-8 · Cited by 331
Retracted
Hypoxia, cancer metabolism and the therapeutic benefit of targeting lactate/H(+) symporters
Marchiq, I., & Pouysségur, J. (2016) · Journal of Molecular Medicine · doi:10.1007/s00109-015-1307-x · Cited by 300
Causes, consequences, and therapy of tumors acidosis
Pillai, S., Damaghi, M., Marunaka, Y., Spugnini, E. P., Fais, S., & Gillies, R. J. (2019) · Cancer and Metastasis Reviews · doi:10.1007/s10555-019-09792-7 · Cited by 286
Short‐Chain Fatty Acid Transporters: Role in Colonic Homeostasis
Sivaprakasam, S., Bhutia, Y. D., Yang, S., & Ganapathy, V. (2017) · Comprehensive physiology · doi:10.1002/cphy.c170014 · Cited by 331
Recent advances in smart hydrogels for biomedical applications: From self-assembly to functional approaches
Ferreira, N. N., Ferreira, L. M. B., Cardoso, V. M. D. O., Boni, F. I., de Souza, A. L. R., & Gremião, M. P. D. (2017) · European Polymer Journal · doi:10.1016/j.eurpolymj.2017.12.004 · Cited by 259
Metabolic reprogramming toward oxidative phosphorylation identifies a therapeutic target for mantle cell lymphoma
Zhang, L., Yao, Y., Zhang, S., Liu, Y., Guo, H., Ahmed, M., Bell, T., Zhang, H., Han, G., Lorence, E., et al. (2019) · Science Translational Medicine · doi:10.1126/scitranslmed.aau1167 · Cited by 233
Carbonic anhydrase IX and acid transport in cancer
Becker, H. M. (2019) · British Journal of Cancer · doi:10.1038/s41416-019-0642-z · Cited by 232
MCT4 Defines a Glycolytic Subtype of Pancreatic Cancer with Poor Prognosis and Unique Metabolic Dependencies
Baek, G., Tse, Y. F., Hu, Z., Cox, D., Buboltz, N., McCue, P. A., Yeo, C. J., White, M. A., DeBerardinis, R. J., Knudsen, E. S., et al. (2014) · Cell Reports · doi:10.1016/j.celrep.2014.11.025 · Cited by 227
Molecular intricacies of aerobic glycolysis in cancer: Current insights into the classic metabolic phenotype
Ganapathy-Kanniappan, S. (2018) · Critical Reviews in Biochemistry and Molecular Biology · doi:10.1080/10409238.2018.1556578 · Cited by 216
Cancer metabolism in space and time: Beyond the Warburg effect
Danhier, P., Bański, P., Payen, V. L., Grasso, D., Ippolito, L., Sonveaux, P., & Porporato, P. E. (2017) · Biochimica et Biophysica Acta (BBA) - Bioenergetics · doi:10.1016/j.bbabio.2017.02.001 · Cited by 230
Metabolic reprogramming in renal cancer: Events of a metabolic disease
Chakraborty, S., Balan, M., Sabarwal, A., Choueiri, T. K., & Pal, S. (2021) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/j.bbcan.2021.188559 · Cited by 214
The HK2 Dependent “Warburg Effect” and Mitochondrial Oxidative Phosphorylation in Cancer: Targets for Effective Therapy with 3-Bromopyruvate
Lis, P., Dyląg, M., Niedźwiecka, K., Ko, Y. H., Pedersen, P. L., Goffeau, A., & Ułaszewski, S. (2016) · Molecules · doi:10.3390/molecules21121730 · Cited by 205
Role of SCFAs in gut microbiome and glycolysis for colorectal cancer therapy
Wang, G., Yu, Y., Wang, Y., Wang, J., Guan, R., Sun, Y., Shi, F., Gao, J., & Fu, X. (2019) · Journal of Cellular Physiology · doi:10.1002/jcp.28436 · Cited by 200
An Integrated Genomic Screen Identifies LDHB as an Essential Gene for Triple-Negative Breast Cancer
McCleland, M. L., Adler, A. S., Shang, Y., Hunsaker, T., Truong, T., Peterson, D., Torres, E., Li, L., Haley, B., Stéphan, J.-P., et al. (2012) · Cancer Research · doi:10.1158/0008-5472.can-12-1098 · Cited by 195
Metabolic adaptation of cancer and immune cells mediated by hypoxia-inducible factors
Samanta, D., & Semenza, G. L. (2018) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/j.bbcan.2018.07.002 · Cited by 190
Targeting monocarboxylate transporters (MCTs) in cancer: How close are we to the clinics?
Singh, M., Afonso, J., Sharma, D., Gupta, R., Kumar, V., Rani, R., Baltazar, F., & Kumar, V. (2023) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2023.01.007 · Cited by 194
Self-citation
Mitochondrial-Targeting Anticancer Agent Conjugates and Nanocarrier Systems for Cancer Treatment
Battogtokh, G., Cho, Y., Lee, J. Y., Lee, H. S., & Kang, H. C. (2018) · Frontiers in Pharmacology · doi:10.3389/fphar.2018.00922 · Cited by 179
Genetic Disruption of Lactate/H+ Symporters (MCTs) and Their Subunit CD147/BASIGIN Sensitizes Glycolytic Tumor Cells to Phenformin
Marchiq, I., LeFloch, R., Roux, D., Simon, M., & Pouysségur, J. (2014) · Cancer Research · doi:10.1158/0008-5472.can-14-2260 · Cited by 182
Are Integrins Still Practicable Targets for Anti-Cancer Therapy?
Alday-Parejo, B., Stupp, R., & Rüegg, C. (2019) · Cancers · doi:10.3390/cancers11070978 · Cited by 181
‘Warburg effect’ controls tumor growth, bacterial, viral infections and immunity – Genetic deconstruction and therapeutic perspectives
Pouysségur, J., Marchiq, I., Parks, S. K., Durivault, J., Ždralević, M., & Vučetić, M. (2022) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2022.07.004 · Cited by 178
Histone lactylation: from tumor lactate metabolism to epigenetic regulation
Yu, X., Yang, J., Xu, J., Pan, H., Wang, W. J., Yu, X., & Shi, S. (2024) · International Journal of Biological Sciences · doi:10.7150/ijbs.91492 · Cited by 187
Metformin and cancer: from the old medicine cabinet to pharmacological pitfalls and prospects
Riedmaier, A. E., Fisel, P., Nies, A. T., Schaeffeler, E., & Schwab, M. G. (2012) · Trends in Pharmacological Sciences · doi:10.1016/j.tips.2012.11.005 · Cited by 161
Therapeutic targeting of the Warburg effect in pancreatic cancer relies on an absence of p53 function
Rajeshkumar, N. V., Dutta, P., Yabuuchi, S., de Wilde, R. F., Martinez, G. V., Le, A., Kamphorst, J. J., Rabinowitz, J. D., Jain, S. K., Hidalgo, M., et al. (2015) · Cancer Research · doi:10.1158/0008-5472.can-15-0108 · Cited by 158
Targeting glucose metabolism enzymes in cancer treatment: current and emerging strategies
Zhang, Y., Li, Q., Huang, Z., Li, B., Nice, E. C., Huang, C., Wei, L., & Zou, B. (2022) · Cancers · doi:10.3390/cancers14194568 · Cited by 144
The role of lactate in cardiovascular diseases
Ouyang, J., Wang, H., & Huang, J. (2023) · Cell Communication and Signaling · doi:10.1186/s12964-023-01350-7 · Cited by 141
Lactate Dehydrogenase B Is Required for the Growth of KRAS-Dependent Lung Adenocarcinomas
McCleland, M. L., Adler, A. S., Deming, L., Cosino, E., Lee, L. B., Blackwood, E. M., Solon, M., Tao, J., Li, L., Shames, D. S., et al. (2012) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-12-2638 · Cited by 131
Integrins and Cell Metabolism: An Intimate Relationship Impacting Cancer
Ata, R., & Antonescu, C. N. (2017) · International Journal of Molecular Sciences · doi:10.3390/ijms18010189 · Cited by 139
MCT4 blockade increases the efficacy of immune checkpoint blockade
Babl, N., Decking, S.-M., Voll, F., Althammer, M., Sala-Hojman, A., Ferretti, R., Korf, C., Schmidl, C., Schmidleithner, L., Nerb, B., et al. (2023) · Journal for ImmunoTherapy of Cancer · doi:10.1136/jitc-2023-007349 · Cited by 145
Roles of pH and the Na + /H + exchanger NHE1 in cancer: From cell biology and animal models to an emerging translational perspective?
Stock, C. M., & Pedersen, S. F. (2016) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2016.12.001 · Cited by 132
A glycolytic phenotype is associated with prostate cancer progression and aggressiveness: a role for monocarboxylate transporters as metabolic targets for therapy
Pértega‐Gomes, N., Felisbino, S. L., Massie, C. E., Vizcaino, J. R., Coelho, R., Sandi, C., Simoes‐Sousa, S., Jurmeister, S., Ramos‐Montoya, A., Asim, M., et al. (2015) · The Journal of Pathology · doi:10.1002/path.4547 · Cited by 128
Self-citation
Hypoxia-mediated upregulation of MCT1 expression supports the glycolytic phenotype of glioblastomas
Miranda‐Gonçalves, V., Granja, S., Martinho, O., Honavar, M., Pojo, M., Costa, B. M., Pires, M. M., Pinheiro, C., Cordeiro, M., Bebiano, G., et al. (2016) · Oncotarget · doi:10.18632/oncotarget.10114 · Cited by 136
Self-citation
Antitumor Activity of 7-Aminocarboxycoumarin Derivatives, a New Class of Potent Inhibitors of Lactate Influx but Not Efflux
Draoui, N., Schicke, O., Seront, E., Bouzin, C., Sonveaux, P., Riant, O., & Féron, O. (2014) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-13-0653 · Cited by 124
Na + /H + antiporter (NHE1) and lactate/H + symporters (MCTs) in pH homeostasis and cancer metabolism
Counillon, L., Bouret, Y., Marchiq, I., & Pouysségur, J. (2016) · Biochimica et Biophysica Acta (BBA) - Molecular Cell Research · doi:10.1016/j.bbamcr.2016.02.018 · Cited by 122
Arginine deiminase resistance in melanoma cells is associated with metabolic reprogramming, glucose dependence, and glutamine addiction
Long, Y., Tsai, W.-B., Wangpaichitr, M., Tsukamoto, T., Savaraj, N., Feun, L. G., & Kuo, M. T. (2013) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-13-0302 · Cited by 121
Role of pH i , and proton transporters in oncogene-driven neoplastic transformation
Reshkin, S. J., Greco, M. R., & Cardone, R. A. (2014) · Philosophical Transactions of the Royal Society B Biological Sciences · doi:10.1098/rstb.2013.0100 · Cited by 121
Metabolic reprogramming results in abnormal glycolysis in gastric cancer: a review
Liu, Y., Zhang, Z., Wang, J., Chen, C., Tang, X., Zhu, J., & Liu, J. (2019) · OncoTargets and Therapy · doi:10.2147/ott.s189687 · Cited by 123
Clinical and Functional Relevance of the Monocarboxylate Transporter Family in Disease Pathophysiology and Drug Therapy
Fisel, P., Schaeffeler, E., & Schwab, M. G. (2018) · Clinical and Translational Science · doi:10.1111/cts.12551 · Cited by 118
A lactate shuttle system between tumour and stromal cells is associated with poor prognosis in prostate cancer
Pértega‐Gomes, N., Vizcaino, J. R., Attig, J., Jurmeister, S., Lopes, C., & Baltazar, F. (2014) · BMC Cancer · doi:10.1186/1471-2407-14-352 · Cited by 119
Self-citation
SLC transporters as a novel class of tumour suppressors: identity, function and molecular mechanisms
Bhutia, Y. D., Babu, E., Ramachandran, S., Yang, S., Thangaraju, M., & Ganapathy, V. (2016) · Biochemical Journal · doi:10.1042/bj20150751 · Cited by 118
The Role of Diet Related Short-Chain Fatty Acids in Colorectal Cancer Metabolism and Survival: Prevention and Therapeutic Implications
Gomes, S., Oliveira, C. S., Azevedo‐Silva, J., Casanova, M. R., Barreto, J., Pereira, H., Chaves, S. R., Rodrigues, L. R., Casal, M., Côrte‐Real, M., et al. (2018) · Current Medicinal Chemistry · doi:10.2174/0929867325666180530102050 · Cited by 116
Self-citation
Monocarboxylate transporters as targets and mediators in cancer therapy response.
Baltazar, F., Pinheiro, C. M., Morais-Santos, F., Azevedo‐Silva, J., Queirós, O., Preto, A., & Casal, M. (2014) · PubMed · doi:10.14670/hh-29.1511 · Cited by 114
Self-citation
Nutrient transporters: the Achilles’ heel of anabolism
McCracken, A. N., & Edinger, A. L. (2013) · Trends in Endocrinology and Metabolism · doi:10.1016/j.tem.2013.01.002 · Cited by 116
3-bromopyruvate (3BP) a fast acting, promising, powerful, specific, and effective “small molecule” anti-cancer agent taken from labside to bedside: introduction to a special issue
Pedersen, P. L. (2012) · Journal of Bioenergetics and Biomembranes · doi:10.1007/s10863-012-9425-4 · Cited by 112
Biocompatible, Crystalline, and Amorphous Bismuth-Based Metal–Organic Frameworks for Drug Delivery
Orellana‐Tavra, C., Köppen, M., Li, A., Stock, N., & Fairen‐Jiménez, D. (2020) · ACS Applied Materials & Interfaces · doi:10.1021/acsami.9b21692 · Cited by 111
DNA Methylation of the SLC16A3 Promoter Regulates Expression of the Human Lactate Transporter MCT4 in Renal Cancer with Consequences for Clinical Outcome
Fisel, P., Kruck, S., Winter, S., Bedke, J., Hennenlotter, J., Nies, A. T., Scharpf, M. O., Fend, F., Stenzl, A., Schwab, M. G., et al. (2013) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-13-1180 · Cited by 109
Molecular Pathways: Targeting MYC-induced Metabolic Reprogramming and Oncogenic Stress in Cancer
Li, B., & Simon, M. C. (2013) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-12-3629 · Cited by 108
Value of pH regulators in the diagnosis, prognosis and treatment of cancer
Granja, S., Tavares‐Valente, D., Queirós, O., & Baltazar, F. (2017) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2016.12.003 · Cited by 109
Self-citation
Targeting myeloid-derived suppressor cells for cancer immunotherapy
Liu, Y., Wei, G., Cheng, W. A., Dong, Z., Sun, H., Lee, V. Y., Cha, S.-C., Smith, D. L., Kwak, L. W., & Qin, H. (2018) · Cancer Immunology Immunotherapy · doi:10.1007/s00262-018-2175-3 · Cited by 110
Cellular Uptake of MCT1 Inhibitors AR-C155858 and AZD3965 and Their Effects on MCT-Mediated Transport of L-Lactate in Murine 4T1 Breast Tumor Cancer Cells
Guan, X., Rodriguez‐Cruz, V., & Morris, M. E. (2019) · The AAPS Journal · doi:10.1208/s12248-018-0279-5 · Cited by 108
The Warburg Effect, Lactate, and Nearly a Century of Trying to Cure Cancer
Spencer, N. Y., & Stanton, R. C. (2019) · Seminars in Nephrology · doi:10.1016/j.semnephrol.2019.04.007 · Cited by 112
The SLC16A Family of Monocarboxylate Transporters (MCTs)—Physiology and Function in Cellular Metabolism, pH Homeostasis, and Fluid Transport
Adijanto, J., & Philp, N. J. (2012) · Current topics in membranes · doi:10.1016/b978-0-12-394316-3.00009-0 · Cited by 101
An overview of MCT1 and MCT4 in GBM: small molecule transporters with large implications.
Park, S. J., Smith, C. P., Wilbur, R. R., Cain, C. P., Kallu, S. R., Valasapalli, S., Sahoo, A., Guda, M. R., Tsung, A. J., & Velpula, K. K. (2018) · Europe PMC (PubMed Central) · Cited by 99
Tumor-stroma metabolic relationship based on lactate shuttle can sustain prostate cancer progression
Sanità, P., Capulli, M., Teti, A. M., Galatioto, G. P., Vicentini, C., Chiarugi, P., Bologna, M., & Angelucci, A. (2014) · BMC Cancer · doi:10.1186/1471-2407-14-154 · Cited by 102
The role of proton dynamics in the development and maintenance of multidrug resistance in cancer
Daniel, C., Bell, C., Burton, C., Harguindey, S., Reshkin, S. J., & Rauch, C. (2013) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2013.01.020 · Cited by 105
Interactions of ion transporters and channels with cancer cell metabolism and the tumour microenvironment
Andersen, A. P., Moreira, J. M. A., & Pedersen, S. F. (2014) · Philosophical Transactions of the Royal Society B Biological Sciences · doi:10.1098/rstb.2013.0098 · Cited by 105
Monocarboxylate Transporters: Therapeutic Targets and Prognostic Factors in Disease
Jones, R., & Morris, M. (2016) · Clinical Pharmacology & Therapeutics · doi:10.1002/cpt.418 · Cited by 100
Cancer-derived extracellular succinate: a driver of cancer metastasis
Kuo, C.-C., Wu, J.-Y., & Wu, K. K. (2022) · Journal of Biomedical Science · doi:10.1186/s12929-022-00878-z · Cited by 107
Prognostic Indications of Elevated MCT4 and CD147 across Cancer Types: A Meta-Analysis
Bovenzi, C. D., Hamilton, J., Tassone, P. T., Johnson, J. M., Cognetti, D. M., Luginbuhl, A., Keane, W. M., Zhan, T., Tuluc, M., Bar‐Ad, V., et al. (2015) · BioMed Research International · doi:10.1155/2015/242437 · Cited by 98
Lactate/pyruvate transporter MCT-1 is a direct Wnt target that confers sensitivity to 3-bromopyruvate in colon cancer
Sprowl-Tanio, S., Habowski, A. N., Pate, K. T., McQuade, M. M., Wang, K., Edwards, R. A., Grün, F., Lyou, Y., & Waterman, M. L. (2016) · Cancer & Metabolism · doi:10.1186/s40170-016-0159-3 · Cited by 101
Enhanced glycolysis, regulated by HIF-1α via MCT-4, promotes inflammation in arsenite-induced carcinogenesis
Luo, F., Zou, Z., Liu, X., Ling, M., Wang, Q., Wang, Q., Lu, L., Shi, L., Liu, Y., Liu, Q., et al. (2017) · Carcinogenesis · doi:10.1093/carcin/bgx034 · Cited by 94
Androgen-responsive and nonresponsive prostate cancer cells present a distinct glycolytic metabolism profile
Vaz, C. V., Alves, M. G., Marques, R., Moreira, P. I., Oliveira, P. F., Maia, C. J., & Socorro, S. (2012) · The International Journal of Biochemistry & Cell Biology · doi:10.1016/j.biocel.2012.08.013 · Cited by 94
Fucoidan Structure and Its Impact on Glucose Metabolism: Implications for Diabetes and Cancer Therapy
Mabate, B., Daub, C. D., Malgas, S., Edkins, A. L., & Pletschke, B. I. (2021) · Marine Drugs · doi:10.3390/md19010030 · Cited by 96
Transport function, regulation, and biology of human monocarboxylate transporter 1 (hMCT1) and 4 (hMCT4)
Kobayashi, M., Narumi, K., Furugen, A., & Iseki, K. (2021) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2021.107862 · Cited by 89
Monocarboxylate Transporters MCT1 and MCT4 Regulate Migration and Invasion of Pancreatic Ductal Adenocarcinoma Cells
Kong, S. C., Nøhr‐Nielsen, A., Zeeberg, K., Reshkin, S. J., Hoffmann, E. K., Novak, I., & Pedersen, S. F. (2016) · Pancreas · doi:10.1097/mpa.0000000000000571 · Cited by 89
CD147 regulates the expression of MCT1 and lactate export in multiple myeloma cells
Walters, D. K., Arendt, B. K., & Jelinek, D. F. (2013) · Cell Cycle · doi:10.4161/cc.26193 · Cited by 86
Tumor metabolism, cancer cell transporters, and microenvironmental resistance
Alfarouk, K. O. (2016) · Journal of Enzyme Inhibition and Medicinal Chemistry · doi:10.3109/14756366.2016.1140753 · Cited by 88
Cell-Autonomous Metabolic Reprogramming in Hypoxia
Schito, L., & Rey, S. (2017) · Trends in Cell Biology · doi:10.1016/j.tcb.2017.10.006 · Cited by 83
Monocarboxylate Transporters 1–4 in NSCLC: MCT1 Is an Independent Prognostic Marker for Survival
Eilertsen, M., Andersen, S., Al‐Saad, S., Kiselev, Y., Dønnem, T., Stenvold, H., Pettersen, I., Al-Shibli, K. I., Richardsen, E. H., Busund, L., et al. (2014) · PLoS ONE · doi:10.1371/journal.pone.0105038 · Cited by 84
Metabolic tricks of cancer cells
Hönigová, K., Navrátil, J., Peltanová, B., Polanska, H. H., Raudenská, M., & Masařík, M. (2022) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/j.bbcan.2022.188705 · Cited by 84
Revisiting the Crabtree/Warburg effect in a dynamic perspective: a fitness advantage against sugar-induced cell death
de Alteriis, E., Cartenì, F., Parascandola, P., Serpa, J., & Mazzoleni, S. (2018) · Cell Cycle · doi:10.1080/15384101.2018.1442622 · Cited by 84
Lactate transporters as therapeutic targets in cancer and inflammatory diseases
Pucino, V., Cucchi, D., & Mauro, C. (2018) · Expert Opinion on Therapeutic Targets · doi:10.1080/14728222.2018.1511706 · Cited by 87
Post-translational protein lactylation modification in health and diseases: a double-edged sword
Gong, H., Zhong, H., Cheng, L., Li, L., & Zhang, D. (2024) · Journal of Translational Medicine · doi:10.1186/s12967-023-04842-9 · Cited by 88
CD147 and MCT1‐potential partners in bladder cancer aggressiveness and cisplatin resistance
Afonso, J., Santos, L. L., Miranda‐Gonçalves, V., Morais, A., Amaro, T., Longatto‐Filho, A., & Baltazar, F. (2014) · Molecular Carcinogenesis · doi:10.1002/mc.22222 · Cited by 80
Self-citation
Glucose addiction in cancer therapy: advances and drawbacks
Granja, S., Pinheiro, C. M., Reis, R. M., Martinho, O., & Baltazar, F. (2015) · Current Drug Metabolism · doi:10.2174/1389200216666150602145145 · Cited by 74
Self-citation
Hypoxia optimises tumour growth by controlling nutrient import and acidic metabolite export
Parks, S. K., Cormerais, Y., Marchiq, I., & Pouysségur, J. (2015) · Molecular Aspects of Medicine · doi:10.1016/j.mam.2015.12.001 · Cited by 80
Links between cancer metabolism and cisplatin resistance
Cocetta, V., Ragazzi, E., & Montopoli, M. (2020) · International review of cytology · doi:10.1016/bs.ircmb.2020.01.005 · Cited by 77
Tumor microenvironmental nutrients, cellular responses, and cancer
Lobel, G. P., Jiang, Y., & Simon, M. C. (2023) · Cell chemical biology · doi:10.1016/j.chembiol.2023.08.011 · Cited by 78
Carbonic Anhydrase IX (CAIX), Cancer, and Radiation Responsiveness
Ward, C., Meehan, J., Gray, M., Kunkler, I. H., Langdon, S. P., & Argyle, D. J. (2018) · Metabolites · doi:10.3390/metabo8010013 · Cited by 76
Colorectal Cancer Cells Increase the Production of Short Chain Fatty Acids by Propionibacterium freudenreichii Impacting on Cancer Cells Survival
Casanova, M. R., Azevedo‐Silva, J., Rodrigues, L. R., & Preto, A. (2018) · Frontiers in Nutrition · doi:10.3389/fnut.2018.00044 · Cited by 74
Self-citation
Vacuolar-ATPase Inhibition Blocks Iron Metabolism to Mediate Therapeutic Effects in Breast Cancer
Schneider, L. S., von Schwarzenberg, K., Lehr, T., Ulrich, M. P., Kubisch-Dohmen, R., Liebl, J., Trauner, D. H., Menche, D., & Vollmar, A. M. (2015) · Cancer Research · doi:10.1158/0008-5472.can-14-2097 · Cited by 74
Synthesis and pharmacological evaluation of carboxycoumarins as a new antitumor treatment targeting lactate transport in cancer cells
Draoui, N., Schicke, O., Fernandes, A. E., Drozak, X., Nahra, F., Dumont, A. O., Douxfils, J., Hermans, E., Dogné, J., Corbau, R., et al. (2013) · Bioorganic & Medicinal Chemistry · doi:10.1016/j.bmc.2013.09.010 · Cited by 72
The anticancer agent 3-bromopyruvate: a simple but powerful molecule taken from the lab to the bedside
Azevedo‐Silva, J., Queirós, O., Baltazar, F., Ułaszewski, S., Goffeau, A., Ko, Y. H., Pedersen, P. L., Preto, A., & Casal, M. (2016) · Journal of Bioenergetics and Biomembranes · doi:10.1007/s10863-016-9670-z · Cited by 74
Self-citation
Attacking the supply wagons to starve cancer cells to death
Selwan, E. M., Finicle, B. T., Kim, S. M., & Edinger, A. L. (2016) · FEBS Letters · doi:10.1002/1873-3468.12121 · Cited by 73

Authors: Pinheiro, C., Longatto-Filho, A., Azevedo-Silva, J., Casal, M., Schmitt, F. C., & Baltazar, F.
Affiliations: University of Minho (PT)
Universidade do Porto (PT)
Corresponding author: Baltazar, Fátima
ORCID: Casal, Margarida
Schmitt, Fernando C.
Baltazar, Fátima
Venue: Journal of Bioenergetics and Biomembranes
Publisher: Springer Science and Business Media LLC
Published: 2012-02
Volume: 44
Issue: 1
Pages: 127-139
ISSN: 0145-479X (ISSN-L)
1573-6881
DOI: 10.1007/s10863-012-9428-1
OpenAlex: W2064926668
Cited by: 368
References: 118
Citations by year: 2026: 4 · 2025: 10 · 2024: 13 · 2023: 23 · 2022: 20 · 2021: 32 · 2020: 34 · 2019: 40 · 2018: 24 · 2017: 33 · 2016: 35 · 2015: 30 · 2014: 33 · 2013: 28 · 2012: 9
FWCI: 2.41
Type: journal article
Language: en
Open access: green
hdl.handle.net
Licence: other-oa
www.springer.com/tdm (tdm)
Locations: Journal of Bioenergetics and Biomembranes (publishedVersion)
PubMed (publishedVersion)
Portuguese National Funding Agency for Science, Research and Technology (RCAAP Project by FCT) (submittedVersion, other-oa)
Topics: Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › Cancer, Hypoxia, and Metabolism
Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Metabolism, Diabetes, and Cancer
Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › Cancer, Lipids, and Metabolism
Keywords: monocarboxylate transporters, lactate transport, pyruvate transport, tumor acidification, tumor microenvironment pH, glycolysis, proton symport, cancer therapy targets, solid tumors, colon cancer, breast cancer, lung cancer, gynecologic cancer, prostate cancer, gastric cancer
MeSH terms: Monocarboxylate Transport Protein 1, Amino Acid Sequence, Animals, Multigene Family, Glycolysis, Humans, Hydrogen-Ion Concentration, Molecular Sequence Data, Neoplasms, Phylogeny, Species Specificity, Lactic Acid, Monocarboxylic Acid Transporters, Symporters, Metabolic Networks and Pathways

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Role of monocarboxylate transporters in human cancers: state of the art

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Citations

Cites

Cited by

Related

Metadata

Record

About these checks